Phase 2 clinical study to evaluate the efficacy and safety of intratumoral BO-112 in combination with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

Autores: Márquez-Rodas, I. ; Fernández de Sanmamed Gutiérrez, Miguel; González-Cao, M.; Arance, A. M.; Berrocal, A.; Castañón Álvarez, Eduardo; Espana, S.; Cerezuela-Fuentes, P.; Rodríguez-Moreno, J. F. ; López-Criado, P.; Oramas, J.; de la Cruz Merino, L.; Dalle, S.; Dutriaux, C.; Charles, J.; Robert, C.; Dreno, B.; Montaudie, H.; Saiag, P.; Sánchez-López, J.; Rojas, M.; Escuin-Ordinas, H.; Pons Sanz, V.; Macia, S.; Quintero, M.